These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20034638)

  • 1. Re: DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers L. Mengual, M. Burset, E. Ars, J. J. Lozano, H. Villavicencio, M. J. Ribal And A. Alcaraz J Urol 2009; 182: 741-748.
    Pfister C; Lamy A; Gobet F; Frebourg T
    J Urol; 2010 Feb; 183(2):825-7; author reply 827-8. PubMed ID: 20034638
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers.
    Mengual L; Burset M; Ars E; Lozano JJ; Villavicencio H; Ribal MJ; Alcaraz A
    J Urol; 2009 Aug; 182(2):741-8. PubMed ID: 19539325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127-136.
    Orsola A; Mullane SA; Bellmunt J
    Eur J Cancer; 2016 Nov; 68():196-197. PubMed ID: 27806880
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
    Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
    Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M
    Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
    van der Kwast TH; Bapat B
    Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray.
    Ewis AA; El-Samman E; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Kanayama HO; Baba Y
    Urol Oncol; 2007; 25(2):120-7. PubMed ID: 17349526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of gene expression patterns in superficial and invasive human bladder cancers].
    Zhou L; Shi BT; Wang SX; Luo Y; Yang L; Zhang LL; Wang XY; He DL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):798-801. PubMed ID: 17565857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying distinct classes of bladder carcinoma using microarrays.
    Dyrskjøt L; Thykjaer T; Kruhøffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF
    Nat Genet; 2003 Jan; 33(1):90-6. PubMed ID: 12469123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer outcome and subtype classification by gene expression.
    Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
    Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
    Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Reeve A; Ogawa O
    J Urol; 2007 Sep; 178(3 Pt 1):1073-9. PubMed ID: 17644138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gene expression patterns in superficial and invasive human bladder cancer.
    Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
    Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models.
    Matsui S; Ito M; Nishiyama H; Uno H; Kotani H; Watanabe J; Guilford P; Reeve A; Fukushima M; Ogawa O
    Bioinformatics; 2007 Mar; 23(6):732-8. PubMed ID: 17237045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9.
    Cai T; Mazzoli S; Mondaini N; Bartoletti R
    Eur Urol; 2008 Apr; 53(4):858-9; author reply 859. PubMed ID: 17920185
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
    Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
    Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.